Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting
Status:
Completed
Trial end date:
2020-09-30
Target enrollment:
Participant gender:
Summary
This is a randomized, open-label trial to assess the safety and efficacy of
hydroxychloroquine, and zinc in combination with either azithromycin or doxycycline in a
higher risk COVID-19 positive outpatient population.